MEASURING CLINICAL DIFFERENCE

Guidance on minimally important clinical difference and trial size is needed
The authors of a randomised controlled trial that compared surgical intervention with rehabilitation in patients with chronic low back pain reported a statistically significant difference of less than 10 points in the Oswestry disability index between groups.
1 They concluded that it "did not clearly exceed the pre-specified minimally important clinical difference," the value used in the sample size calculation. It is important to note that the use of a value in the sample size calculation does not make it the minimally important clinical difference, as acknowledged by the authors. The 10 points difference was not justified other than to reference another trial, 2 which itself provided no justification. We support the view that the reporting of how sample size is determined requires greater clarity and transparency and acknowledgment of the discussion that takes place during trial design. 
